Helen Segal

Helen Segal is a seasoned professional in regulatory affairs, currently serving as the Director of Regulatory Affairs at Kyverna Therapeutics. Previously, Helen held the position of Director and Associate Director of Regulatory Affairs CMC at Sana Biotechnology, Inc. and worked as a Senior Manager of Regulatory Affairs at Iovance Biotherapeutics, Inc. Early career roles include Regulatory Affairs Scientist and Process Development and Manufacturing Scientist at Stanford University. Helen began an academic path as a Graduate Student at the California Institute of Technology, where a PhD in Chemistry was obtained from 2010 to 2016, following an ScB in Chemistry from Brown University from 2006 to 2010.